Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC Mechanism of Action in Bipolar Disorder
NCT05340504Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in bipolar disorder (BD), sponsored by Medical University of South Carolina. Started May 2022; status: completed.
02
Drugs
acetylcysteine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05340504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05340504.